OncologyInformationService
Real World Databases
Evidence based Healthcare and Market Research
Evidence based Healthcare and Market Research
Current Online Studies
- [:de]National: TherapieMonitor Multiples Myelom 1. Halbjahr 2018[:en]National: TherapieMonitor Multiples Myelom 1. Halbjahr 2018[:]
- [:de]National: TherapieMonitor Multiples Myelom 1. Quartal 2018[:en]National: TherapieMonitor Multiples Myelom 1. Quartal 2018[:]
- [:de]TherapieMonitor ALK+ NSCLC IIIb/IV 2017/2018 [:en]TherapieMonitor ALK+ NSCLC IIIb/IV 2017/2018[:]
- [:de]TherapieMonitor HGS Ovarialkarzinom 2. Quartal 2018[:en]TherapieMonitor HGS Ovarialkarzinom 2. Quartal 2018 [:]
- [:de]TherapieMonitor Hochgradig Seröses Ovarialkarzinom 2016[:en]TherapieMonitor Hochgradig Seröses Ovarialkarzinom 2016[:]
- [:de]TherapieMonitor Malignes Melanom August 2018[:en]TherapieMonitor Malignes Melanom August 2018[:]
- [:de]TherapieMonitor NSCLC IIIb-IV 1. Halbjahr 2018[:en]TherapieMonitor NSCLC IIIb-IV 1. Halbjahr 2018[:]
- [:de]TherapieMonitor Urothelkarzinom Stadium IV August 2018[:en]TherapieMonitor Urothelkarzinom Stadium IV August 2018[:]
- [:de]TherapieMonitor Urothelkarzinom Stadium IV, 2. Halbjahr 2017[:en]TherapieMonitor Urothelkarzinom Stadium IV, 2. Halbjahr 2017[:]
- [:de]United Kingdom: TherapieMonitor HGS Ovarian Cancer 2016 UK[:en]United Kingdom: TherapieMonitor HGS Ovarian Cancer 2016 UK[:]